Lake Street Advisors Group LLC Sells 80 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Lake Street Advisors Group LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,658 shares of the company’s stock after selling 80 shares during the period. Lake Street Advisors Group LLC’s holdings in HCA Healthcare were worth $798,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. FMR LLC lifted its position in HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of HCA Healthcare by 120.1% during the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock worth $262,264,000 after acquiring an additional 476,756 shares during the last quarter. Meritage Group LP bought a new position in HCA Healthcare in the third quarter valued at $150,548,000. Canoe Financial LP boosted its holdings in shares of HCA Healthcare by 226,952.9% in the 4th quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after purchasing an additional 231,492 shares in the last quarter. Finally, Holocene Advisors LP raised its holdings in shares of HCA Healthcare by 210.6% during the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after buying an additional 208,015 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $319.65 on Thursday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The firm has a market capitalization of $79.38 billion, a PE ratio of 14.55, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64. The company has a 50-day simple moving average of $314.65 and a two-hundred day simple moving average of $350.12. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the business earned $5.90 earnings per share. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.90%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Morgan Stanley decreased their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Finally, Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.